Clinical trial
Treatment of Moderate to Severe Coronavirus Disease (COVID-19) in Hospitalized Patients
NCT04321993 is registered in ClinicalTrials.gov with Lisa Barrett as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treatment of Moderate to Severe Coronavirus Disease (COVID-19) in Hospitalized Patients
- Lead sponsor
- Lisa Barrett
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- April 17, 2020
- Completion date
- April 30, 2024
- Enrollment
- 363 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.